Vantage Consulting Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-89
Closed -$11K 1824
2020
Q4
$11K Buy
+89
New +$9.95K ﹤0.01% 1172

Other funds holding PRAH

Vantage Consulting Group's PRAH Position: Q1 2021 in Review

Vantage Consulting Group sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 89 shares — an estimated $11K sold.

Vantage Consulting Group first reported a position in PRAH in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Vantage Consulting Group reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 89 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $11K.
  • Vantage Consulting Group first reported a position in PRA Health Sciences, Inc. in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's PRA Health Sciences, Inc. position peaked at $11K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.